相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunagenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I. Bernstein et al.
LANCET INFECTIOUS DISEASES (2020)
The Way Forward: Potentiating Protective Immunity to Novel and Pandemic Influenza Through Engagement of Memory CD4 T Cells
Andrea J. Sant
JOURNAL OF INFECTIOUS DISEASES (2019)
Influenza Vaccines: Good, but We Can Do Better
Catharine I. Paules et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain
Florian Krammer et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection
Maryna C. Eichelberger et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
Masaru Kanekiyo et al.
NATURE IMMUNOLOGY (2019)
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
Kizzmekia S. Corbett et al.
MBIO (2019)
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
Sandhya Bangaru et al.
CELL (2019)
Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism
Akiko Watanabe et al.
CELL (2019)
Development of Influenza B Universal Vaccine Candidates Using the Mosaic Hemagglutinin Approach
Weina Sun et al.
JOURNAL OF VIROLOGY (2019)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
Felix Broecker et al.
NPJ VACCINES (2019)
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine
Kenta Matsuda et al.
SCIENCE IMMUNOLOGY (2019)
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial
Cristina Carter et al.
PLOS ONE (2019)
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
Daniel Stadlbauer et al.
SCIENCE (2019)
Immunity to Influenza: Catching a Moving Target To Improve Vaccine Design
Catharine I. Paules et al.
JOURNAL OF IMMUNOLOGY (2019)
With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination
Marios Koutsakos et al.
JOURNAL OF IMMUNOLOGY (2019)
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
Pedro M. Folegatti et al.
VACCINES (2019)
Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody
Donald D. Raymond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Is It Possible to Develop a Universal Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem
Sarah F. Andrews et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
Jason K. H. Lee et al.
EXPERT REVIEW OF VACCINES (2018)
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Peter D. Kwong et al.
IMMUNITY (2018)
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
Emily J. Erbelding et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
Rory D. de Vries et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence
Xianqiang Ping et al.
VACCINE (2018)
Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus
Jae-Keun Park et al.
MBIO (2018)
A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA
Sandhya Bangaru et al.
NATURE COMMUNICATIONS (2018)
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
Hadi M. Yassine et al.
SCIENTIFIC REPORTS (2018)
Immune responses after live attenuated influenza vaccination
Kristin G. -I. Mohn et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation
James D. Allen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Cell culture-derived flu vaccine: Present and future
Alberto Perez Rubio et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
Daniela S. Rajao et al.
FRONTIERS IN MICROBIOLOGY (2018)
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
L. Coughlan et al.
EBIOMEDICINE (2018)
Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model
Alison Han et al.
BMC INFECTIOUS DISEASES (2018)
A Synthetic Micro-Consensus DNA Vaccine Generates Comprehensive Influenza A H3N2 Immunity and Protects Mice Against Lethal Challenge by Multiple H3N2 Viruses
Sarah T. C. Elliott et al.
HUMAN GENE THERAPY (2018)
Development of a Pan-H1 Influenza Vaccine
Nicole Darricarrere et al.
JOURNAL OF VIROLOGY (2018)
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Norbert Pardi et al.
NATURE COMMUNICATIONS (2018)
Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus
Kaitlyn M. Morabito et al.
FRONTIERS IN IMMUNOLOGY (2018)
Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections
Valentina Bernasconi et al.
FRONTIERS IN IMMUNOLOGY (2018)
AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
Surender Khurana et al.
NPJ VACCINES (2018)
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
Katherine Houser et al.
PLOS ONE (2018)
Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs
E. R. Job et al.
NPJ VACCINES (2018)
Immune History and Influenza Vaccine Effectiveness
Joseph A. Lewnard et al.
VACCINES (2018)
Clinical Advances in Viral-Vectored Influenza Vaccines
Sarah Sebastian et al.
VACCINES (2018)
M2-based influenza vaccines: recent advances and clinical potential
Annasaheb Kolpe et al.
EXPERT REVIEW OF VACCINES (2017)
Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses
Catherine M. Crosby et al.
JOURNAL OF VIROLOGY (2017)
The Pathway to a Universal Influenza Vaccine
Catharine I. Paules et al.
IMMUNITY (2017)
A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus
Nicholas C. Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants
Terianne M. Wong et al.
JOURNAL OF VIROLOGY (2017)
Development of an Alternative Modified Live Influenza B Virus Vaccine
Jefferson J. S. Santos et al.
JOURNAL OF VIROLOGY (2017)
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine Phase IIb study protocol
Eva van Doorn et al.
MEDICINE (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Lisa M. Dunkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy
Srinivasa Reddy Bonam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain
George H. Lowell et al.
VACCINE (2017)
Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis
Krista Wilkinson et al.
VACCINE (2017)
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza
Yasuko Hatta et al.
VACCINE (2017)
Basic principles of test-negative design in evaluating influenza vaccine effectiveness
Wakaba Fukushima et al.
VACCINE (2017)
A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus
Shin-Hee Kim et al.
VIROLOGY (2017)
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
Madhusudan Rajendran et al.
MBIO (2017)
Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
Sinthujan Jegaskanda et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
Adam D. DeZure et al.
NPJ VACCINES (2017)
A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques
Nicholas W. Florek et al.
PLOS ONE (2017)
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
Neal Van Hoeven et al.
SCIENTIFIC REPORTS (2017)
Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans
Sarah F. Andrews et al.
SCIENCE IMMUNOLOGY (2017)
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for asingle-center, randomized, double-blind and placebo-controlled clinical phase IIb trial
Eva van Doorn et al.
BMC INFECTIOUS DISEASES (2017)
Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
JOURNAL OF VIROLOGY (2016)
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production
Felipe Tapia et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
M. Gordon Joyce et al.
CELL (2016)
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
Nicole L. Kallewaard et al.
CELL (2016)
A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
Stephan Pillet et al.
CLINICAL IMMUNOLOGY (2016)
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2016)
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain
Donald D. Raymond et al.
NATURE MEDICINE (2016)
High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses
Jin Hyang Kim et al.
VACCINE (2016)
The 2015 global production capacity of seasonal and pandemic influenza vaccine
Kenneth A. McLean et al.
VACCINE (2016)
Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines
Jennifer Mullin et al.
VACCINE (2016)
M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice
Sally Sarawar et al.
VACCINE (2016)
Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine
Mariette F. Ducatez et al.
VETERINARY MICROBIOLOGY (2016)
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
Matthew J. Memoli et al.
MBIO (2016)
A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve
Ying Fu et al.
NATURE COMMUNICATIONS (2016)
Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine
Nuriban Valero-Pacheco et al.
PLOS ONE (2016)
Prospects for Broadly Protective Influenza Vaccines
John Jay Treanor
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2015)
Viral Receptor-Binding Site Antibodies with Diverse Germline Origins
Aaron G. Schmidt et al.
CELL (2015)
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
Julie E. Ledgerwood et al.
CONTEMPORARY CLINICAL TRIALS (2015)
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
Nikolai Petrovsky
DRUG SAFETY (2015)
Current and next generation influenza vaccines: Formulation and production strategies
Peter C. Soema et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
Arnold S. Monto et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses
Qinfang Liu et al.
JOURNAL OF VIROLOGY (2015)
High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
David Liebowitz et al.
LANCET INFECTIOUS DISEASES (2015)
Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis
Hector S. Izurieta et al.
LANCET INFECTIOUS DISEASES (2015)
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hadi M. Yassine et al.
NATURE MEDICINE (2015)
Advances in the development of influenza virus vaccines
Florian Krammer et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults
Michelle C. Crank et al.
PLOS ONE (2015)
DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial
Julie E. Ledgerwood et al.
PLOS ONE (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets
Ye V. Liu et al.
VACCINE (2015)
Virus-specific T cells as correlate of (cross-)protective immunity against influenza
Arwen F. Altenburg et al.
VACCINE (2015)
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
MBIO (2015)
A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus
Ying Wu et al.
NATURE COMMUNICATIONS (2015)
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review
Barbara Camilloni et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1) pdm09 Dose-Finding Investigational New Drug Study
Matthew J. Memoli et al.
CLINICAL INFECTIOUS DISEASES (2015)
Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ
Anthony L. Desbien et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
Eleanor L. Ramos et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Characterization of Drug-Resistant Influenza Virus A(H1N1) and A(H3N2) Variants Selected In Vitro with Laninamivir
Melanie Samson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
Florian Krammer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines
Jennifer M. Radin et al.
CLINICAL INFECTIOUS DISEASES (2014)
H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene
Attapon Kamlangdee et al.
JOURNAL OF VIROLOGY (2014)
Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques
Kelsey R. Florek et al.
JOURNAL OF VIROLOGY (2014)
Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages
James R. R. Whittle et al.
JOURNAL OF VIROLOGY (2014)
Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
Raffael Nachbagauer et al.
JOURNAL OF VIROLOGY (2014)
Characterization of a Broadly Neutralizing Monoclonal Antibody That Targets the Fusion Domain of Group 2 Influenza A Virus Hemagglutinin
Gene S. Tan et al.
JOURNAL OF VIROLOGY (2014)
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Joost H. C. M. Kreijtz et al.
LANCET INFECTIOUS DISEASES (2014)
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
Richard D. Antrobus et al.
MOLECULAR THERAPY (2014)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
Annett Hessel et al.
PLOS ONE (2014)
GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
Christopher H. Clegg et al.
PLOS ONE (2014)
A common solution to group 2 influenza virus neutralization
Robert H. E. Friesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
Ali H. Ellebedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Priming by a novel universal influenza vaccine (Multimeric-001)-A gateway for improving immune response in the elderly population
Jacob Atsmon et al.
VACCINE (2014)
Safety and immunogenicity of a virus-like, particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
Jenny G. H. Low et al.
VACCINE (2014)
Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus
Peter S. Lee et al.
NATURE COMMUNICATIONS (2014)
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains
Barbara Camilloni et al.
IMMUNITY & AGEING (2014)
An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
Gerald Nakamura et al.
CELL HOST & MICROBE (2013)
Traditional and New Influenza Vaccines
Sook-San Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine
Caitlin E. Mullarkey et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
Robert B. Couch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
Hongquan Wan et al.
JOURNAL OF VIROLOGY (2013)
Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site
Minsun Hong et al.
JOURNAL OF VIROLOGY (2013)
Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
Cyrille Dreyfus et al.
JOURNAL OF VIROLOGY (2013)
Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
I. Margine et al.
JOURNAL OF VIROLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
Janet E. McElhaney et al.
LANCET INFECTIOUS DISEASES (2013)
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
Marc Gurwith et al.
LANCET INFECTIOUS DISEASES (2013)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar et al.
NATURE MEDICINE (2013)
A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin
Rui Xu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
Louis F. Fries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody
Aaron G. Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses
Rafael A. Medina et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
Wendy Peters et al.
VACCINE (2013)
Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE plus GLA) adjuvant
John J. Treanor et al.
VACCINE (2013)
Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus
Amy C. Boyd et al.
VACCINE (2013)
Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus
R. L. Vander Veen et al.
VETERINARY RECORD (2013)
New World Bats Harbor Diverse Influenza A Viruses
Suxiang Tong et al.
PLOS PATHOGENS (2013)
Preliminary Assessment of the Efficacy of a T-Cell-Based Influenza Vaccine, MVA-NP+M1, in Humans
Patrick J. Lillie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
Jens C. Krause et al.
JOURNAL OF VIROLOGY (2012)
Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
Rong Hai et al.
JOURNAL OF VIROLOGY (2012)
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C. Ekiert et al.
NATURE (2012)
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
Tom M. Wilkinson et al.
NATURE MEDICINE (2012)
A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
Richard D. Antrobus et al.
PLOS ONE (2012)
Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity
Peter S. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine
Ryan L. Vander Veen et al.
VACCINE (2012)
Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
Jianhua Sui et al.
CLINICAL INFECTIOUS DISEASES (2011)
Influenza viral neuraminidase: the forgotten antigen
Bert E. Johansson et al.
EXPERT REVIEW OF VACCINES (2011)
Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
Karim El Bakkouri et al.
JOURNAL OF IMMUNOLOGY (2011)
A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin
Jens C. Krause et al.
JOURNAL OF VIROLOGY (2011)
Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5
Nobuko Ohshima et al.
JOURNAL OF VIROLOGY (2011)
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
Julie E. Ledgerwood et al.
LANCET INFECTIOUS DISEASES (2011)
Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
Lamberto Manzoli et al.
PLOS ONE (2011)
A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
Glendie Marcelin et al.
PLOS ONE (2011)
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
James R. R. Whittle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin
Ming-Wei Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
Brendan M. Giles et al.
VACCINE (2011)
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)
David N. Taylor et al.
VACCINE (2011)
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults
Christine B. Turley et al.
VACCINE (2011)
Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates
Jason T. Weinfurter et al.
PLOS PATHOGENS (2011)
Molecular Characterization of In Vivo Adjuvant Activity in Ferrets Vaccinated against Influenza Virus
Yuan Fang et al.
JOURNAL OF VIROLOGY (2010)
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
Gary J. Nabel et al.
NATURE MEDICINE (2010)
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Chih-Jen Wei et al.
SCIENCE (2010)
The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response
Zhongying Chen et al.
VACCINE (2010)
AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice
Catherine Caillet et al.
VACCINE (2010)
Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
Taia T. Wang et al.
PLOS PATHOGENS (2010)
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
Guus F. Rimmelzwaan et al.
EXPERT REVIEW OF VACCINES (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
Tino F. Schwarz et al.
VACCINE (2009)
Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses
Reiko Yoshida et al.
PLOS PATHOGENS (2009)
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
David I. Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
Mark Throsby et al.
PLOS ONE (2008)
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
Arun K. Kashyap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin
James W. Huleatt et al.
VACCINE (2008)
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza
Bolyn Hubby et al.
VACCINE (2007)
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans
Matthew R. Sandbulte et al.
PLOS MEDICINE (2007)
Evidence of a cross-protective immune response to influenza A in the cotton rat model
Timothy M. Straight et al.
VACCINE (2006)
Influenza type a virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2
D Zharikova et al.
JOURNAL OF VIROLOGY (2005)
Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus
RD Wesley et al.
VACCINE (2004)
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
CL Cooper et al.
VACCINE (2004)
CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells
A Krug et al.
JOURNAL OF IMMUNOLOGY (2003)
N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin
R Daniels et al.
MOLECULAR CELL (2003)
Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-Like H5N1 influenza virus is correlated with the proportion of pulmonary CD8+ T cells expressing gamma interferon
SH Seo et al.
JOURNAL OF VIROLOGY (2002)
An antibody that prevents the hemagglutinin low pH fusogenic transition
C Barbey-Martin et al.
VIROLOGY (2002)
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
G Hartmann et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
